Koers Shanghai Rightongene Biotechnology Co., Ltd.
Aandelen
688217
CNE100005212
Medische apparatuur, benodigdheden & distributie
slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
23,95 CNY | +0,34% | +6,40% | -33,06% |
Omzet 2024 * | 311 mln. 42,92 mln. 40,14 mln. | Omzet 2025 * | 375 mln. 51,75 mln. 48,4 mln. | Marktkapitalisatie | 1,34 mld. 185 mln. 173 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 12 mln. 1,66 mln. 1,55 mln. | Nettowinst (verlies) 2025 * | 14 mln. 1,93 mln. 1,81 mln. | EV/omzet 2024 * | 4,3 x |
Nettoliquiditeiten 2024 * | - 0 0 | Nettoliquiditeiten 2025 * | - 0 0 | EV/omzet 2025 * | 3,57 x |
K/w-verhouding 2024 * |
114
x | K/w-verhouding 2025 * |
95,8
x | Werknemers | 501 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 57,42% |
1 dag | +0,34% | ||
1 week | +6,40% | ||
Lopende maand | -13,04% | ||
1 maand | -12,08% | ||
3 maanden | -21,24% | ||
6 maanden | -33,58% | ||
Lopend jaar | -33,06% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Hui Xiong
CEO | Chief Executive Officer | 52 | 17-02-12 |
Yan Li
DFI | Director of Finance/CFO | 42 | 27-03-20 |
Jun Xiong
BRD | Director/Board Member | 48 | 01-01-15 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Xue Wei Yuan
BRD | Director/Board Member | 52 | 13-12-18 |
Gui Ying Zhao
BRD | Director/Board Member | 70 | 13-12-18 |
Guang Ce Jiang
BRD | Director/Board Member | 53 | 24-08-23 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
26-04-24 | 23,95 | +0,34% | 152 256 |
25-04-24 | 23,87 | +1,23% | 203 996 |
24-04-24 | 23,58 | +2,34% | 241 130 |
23-04-24 | 23,04 | +0,83% | 178 168 |
22-04-24 | 22,85 | +1,51% | 201 333 |
slotkoers Shanghai S.E., 26 april 2024
Meer koersenHerzieningen van WPA
Winst van het jaar - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
-33,06% | 184 mln. | |
+0,89% | 12,59 mld. | |
-10,29% | 7,42 mld. | |
+1,78% | 5,35 mld. | |
-1,16% | 4,51 mld. | |
+5,74% | 4,47 mld. | |
-50,70% | 3,21 mld. | |
+12,21% | 2,71 mld. | |
-16,13% | 1,96 mld. | |
-11,50% | 1,73 mld. |